2-Substituted-N-3-[3-(1-piperidinomethyl)phenoxy]propyl}acetamide, derivatives thereof, and pharmaceutically acceptable salts thereof. The substitution group may be aminomethylcyclohexane carbonyl group or N-carbobenzoxy-p-aminomethylhexane carbonyl group. The compounds having the first-mentioned group can be an effective component of an antiulcer drug composition, and the compounds of the last-mentioned group are intermediates for producing the compounds having the first-mentioned group. Disclosed also is an antiulcer drug composition comprising the above compound as an effective component. The antiulcer drug composition exhibits both the gastric acid secretion inhibitive activity and the gastric mucosa protective activity, and is effective as suppression and cure of ulcers.
2-取代基-N-3-[3-(1-
哌啶甲基)苯氧基]丙基}乙酰胺、其衍
生物及其药学上可接受的盐类。取代基可以是
氨甲基环己烷羰基或 N-羧基苯氧基-对
氨甲基环己烷羰基。具有前述基团的化合物可作为抗溃疡药物组合物的有效成分,而后述基团的化合物则是生产具有前述基团的化合物的中间体。还公开了一种抗溃疡药物组合物,其中包含上述化合物作为有效成分。该抗溃疡药物组合物同时具有胃酸分泌抑制活性和胃黏膜保护活性,可有效抑制和治疗溃疡。